- $228.44m
- $178.20m
- $616.56m
- 93
- 97
- 24
- 83
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 68.16 | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | -77.83% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.71 | ||
| Price to Tang. Book | 0.92 | ||
| Price to Free Cashflow | 3.54 | ||
| Price to Sales | 0.37 | ||
| EV to EBITDA | 4.91 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.11% | ||
| Return on Equity | 6.43% | ||
| Operating Margin | 3.31% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 94.09 | 318.72 | 440.52 | 624.29 | 616.56 | 410.49 | 446.17 | 59.99% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +41.9 | -79.79 | +206.68 | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
DocGo Inc. is a mobile healthcare services company that uses dispatch and communication technology to help provide mobile, in-person medical treatment directly to patients in the comfort of their homes, workplaces and other non-traditional locations and healthcare transportation in major metropolitan cities in the United States and the United Kingdom. The Company’s offerings also include mobile phlebotomy lab services, which is engaged in addressing critical gaps in diagnostic care for underserved populations. The Mobile Health Services include a variety of healthcare services performed at homes, offices and other locations and event services, such as on-site healthcare support at sporting events and concerts. The Transportation Services encompass both emergency response and non-emergency transport services. Non-emergency transport services include ambulance transports and wheelchair transports.
Directors
- Last Annual
- December 31st, 2024
- Last Interim
- December 31st, 2024
- Incorporated
- August 11th, 2020
- Public Since
- October 15th, 2020
- No. of Shareholders
- 57
- No. of Employees
- 3,404
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 99,104,331
- Address
- 685 Third Avenue, 9Th Floor, NEW YORK, 10017
- Web
- https://www.docgo.com/
- Phone
- +1 2128188800
- Auditors
- Urish (Popeck) & Company
Upcoming Events for DCGO
Q1 2025 DocGo Inc Earnings Call
DocGo Inc Annual Shareholders Meeting
Q2 2025 DocGo Inc Earnings Release
Similar to DCGO
ADVANCED BIOMED
NASDAQ Capital Market
IMEI Technology Health
NASDAQ Capital Market
Akanda
NASDAQ Capital Market
Astrana Health
NASDAQ Capital Market
Basel Medical
NASDAQ Capital Market
FAQ
What is the DocGo share price?
As of Today at 20:17 UTC, shares in DocGo are trading at $2.24. This share price information is delayed by 15 minutes.
How has the DocGo share price performed this year?
Shares in DocGo last closed at $2.24 and the price had moved by -35.82% over the past 365 days. In terms of relative price strength the DocGo share price has underperformed the S&P500 Index by -40.76% over the past year.
What are the analyst and broker recommendations for DocGo?
The overall consensus recommendation for DocGo is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreWhat is the DocGo dividend yield?
DocGo does not currently pay a dividend.
Does DocGo pay a dividend?
DocGo does not currently pay a dividend.
When does DocGo next pay dividends?
DocGo does not currently pay a dividend.
How do I buy DocGo shares?
To buy shares in DocGo you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of DocGo?
As of the previous close price of $2.24, shares in DocGo had a market capitalisation of $228.44m.
Where are DocGo shares listed?
Here are the trading details for DocGo:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: DCGO
What kind of share is DocGo?
Based on an overall assessment of its quality, value and momentum DocGo is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a DocGo share price forecast for 2025?
The analyst consensus target price for shares in DocGo is $5.05. That is 125.45% above the last closing price of $2.24.
Analysts covering DocGo currently have a consensus Earnings Per Share (EPS) forecast of -$0.00 for the next financial year.
Find out moreWhat is the trend in the DocGo share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like DocGo. Over the past six months, its share price has underperformed the S&P500 Index by -30.97%.
As of the last closing price of $2.24, shares in DocGo were trading -38.63% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the DocGo PE Ratio?
The DocGo PE ratio based on its reported earnings over the past 12 months is 68.16. The shares last closed at $2.24.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of DocGo?
We do not have data on DocGo's directors